South Korea’s SK Group Makes Biotech Push With $1.3 Billion IPO Of Covid Vaccine Unit The IPO of SK Bioscience is the latest push by Korean billionaire Chey Tae-won’s SK Group—which is known for its memory chip and electric vehicle battery businesses—to expand into another hot market: Biotech.